Author： Terpos Evangelos Roussou Maria Dimopoulos Meletios-Athanassios
Publisher： Informa Healthcare
ISSN： 1742-5255
Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.5, 2008-05, pp. : 639-654
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bortezomib for multiple myeloma
By Popat Rakesh Joel Simon Oakervee Heather Cavenagh Jamie
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 10, 2006-07 ,pp. :
Access to resources
Recommend
An expanding VISTA for bortezomib in multiple myeloma
Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. :
Bortezomib battles the front line in multiple myeloma
Inpharma, Vol. 1, Iss. 1477, 2005-01 ,pp. :
Bortezomib: A Review of its Use in Patients with Multiple Myeloma
By Curran Monique P. McKeage Kate
Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. :